So far, overexpressed EIF3C has been determined in a variety of tumors, such as ovarian cancer, colon cancer, renal cell carcinoma and cervical cancer, but few studies have mentioned NPC (Liu et al. 2020; Song et al. 2013; Fan et al. 2019; Hu et al. 2019). Here, EIF3C is linked to nasopharyngeal carcinoma.